Form 4 for ADMA ADMA BIOLOGICS, INC.

Accepted 2024-02-28 00:00:00 ET · period of report 2024-02-26 · accession 0001140361-24-010239 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2024-02-28	2024-02-26	ADMA	KWON YOUNG	Dir	A - Grant	$0.00	+24.0K	301.4K	+9%	$0
D	2024-02-28	2024-02-26	ADMA	KWON YOUNG	Dir	A - Grant	$0.00	+37.5K	37.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2024-02-26	A	A	24,040	$0.00	301,441	D	—	—	(F1) These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date. (F2) Includes, as of the transaction date, (i) 24,040 RSUs granted on February 26, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 25,815 RSUs granted on March 6, 2023, which will vest in full on March 6, 2024; and (iii) 251,586 shares of common stock owned by the reporting person.
2	Derivative	Stock Option (right to buy)	2024-02-26	A	A	37,541	$0.00	37,541	D	$5.40 · — to 2034-02-26	37,541 Common Stock	(F3) The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.